Advair Diskus
100/50 · 250/50 · 500/50mcg
This inhaler is developed to target chronic obstructive pulmonary disease and is indicated to alleviate airway inflammation.
Respiratory health medicines cover asthma, COPD, airway inflammation, bronchospasm, mucus symptoms, and selected lung complications. This category is most useful when you separate reliever treatment, preventer treatment, and long-term control.
100/50 · 250/50 · 500/50mcg
This inhaler is developed to target chronic obstructive pulmonary disease and is indicated to alleviate airway inflammation.
50/250mg
formulated to alleviate symptoms of asthma and intended to target airway inflammation to support improved respiratory function.
Bromhexine, Guaifenesin, Menthol, Terbutaline
100ml
developed for respiratory congestion to manage mucus clearance.
100/6 · 160/4.5 · 200/6 · 400/6mcg
indicated to relieve airway obstruction and inflammation to alleviate breathing difficulties.
100/6 · 200/6 · 400/6mcg
utilized to alleviate airway inflammation, to support respiratory function.
100 · 200mcg
developed to target bronchial inflammation to manage airway hyperactivity in respiratory conditions.
Levosalbutamol, Ipratropium Bromide
50/20mcg
Utilized to manage bronchospasm to alleviate respiratory distress.
50/20mcg
Formulated to target airway constriction and indicated to support effective breathing in respiratory conditions.
500mg
Product intended to target chronic obstructive pulmonary disease and formulated to alleviate respiratory inflammation.
200 · 400mg
utilized to manage idiopathic pulmonary fibrosis to alleviate lung fibrosis progression.
Fluticasone Propionate, Salmeterol
250/50 · 500/50mcg
Indicated to manage asthma and chronic obstructive pulmonary disease and to alleviate respiratory inflammation by opening airways and reducing swelling.
100mg
indicated to alleviate disease progression in idiopathic pulmonary fibrosis, to support respiratory function.
100mcg
Indicated to relieve wheezing and formulated to target bronchospasm in asthma and respiratory conditions.
100mcg
developed to alleviate symptoms of asthma and utilized to support respiratory function by dilating airways during exacerbations.
100 · 200mcg
Intended to mitigate airway inflammation, formulated to support respiratory function and help manage symptoms of chronic asthma or lung conditions.
200mcg
formulated to address chronic airway inflammation to alleviate breathing difficulties in asthma.
100mcg
Developed to target inflammation in nasal passages, indicated to alleviate symptoms of allergic rhinitis.
500mg
indicated to manage inflammatory processes in the airways, utilizing enzyme inhibition to support reduction in exacerbations for patients with underlying respiratory conditions.
100mcg
Indicated to address bronchospasm in asthma and COPD patients and to alleviate breathing difficulties by relaxing muscles in the airways.
25/125 · 25/250mcg
Utilized to target asthma and COPD to support respiratory function.
4 · 5 · 10mg
Developed to target inflammation in the airways, intended to support the management of persistent asthma and allergic rhinitis by blocking leukotrienes.
9mcg
This inhaler is indicated to relieve chronic obstructive pulmonary disease and is developed to support improved respiratory function.
160/4.5mcg
Designed to manage asthma and chronic obstructive pulmonary disease, intended to alleviate airway inflammation and support breathing function in patients.
400mg
Formulated to mitigate respiratory restriction and indicated to support ease of breathing.
200mg
designed to target constricted airways, promoting improved airflow and reducing breathing difficulty.
400mg
Indicated to address airway obstruction, formulated to support bronchial relaxation and to address respiratory distress.
9mcg
This inhaler is formulated to support respiratory function and indicated to alleviate airway narrowing in chronic obstructive pulmonary disease.
9mcg
Indicated for chronic obstructive pulmonary disease, formulated to alleviate breathing difficulties and support respiratory function in patients managing long-term lung health.
15caps
Developed to alleviate chronic obstructive pulmonary disease to support better airway function and facilitate ease of breathing.
Breathing medicines often work locally in the lungs, so inhaler technique can decide whether a good medicine works poorly. Symptoms such as wheeze, cough, breathlessness, night waking, and exercise limitation help guide treatment review.
Asthma and COPD can share symptoms but differ in triggers, inflammation patterns, and treatment plans. Frequent reliever use is a clue that prevention or diagnosis may need review.
Bronchodilators relax airway muscle to improve airflow. Short-acting relievers work quickly; long-acting medicines support control and are often combined with preventer therapy where appropriate.
Steroid inhalers reduce airway inflammation and are central to many asthma plans. Combination inhalers pair inflammation control with long-acting airway relaxation.
Some respiratory medicines are tablets or liquids used for inflammation, mucus, or specific lung conditions. Their role depends on diagnosis and severity.
Poor inhaler technique, expired inhalers, and missing a preventer can look like treatment failure. Technique review is often worth doing before changing medicines.
Respiratory medicines can interact with beta blockers, diuretics, heart rhythm medicines, steroids, and some antidepressants.
Respiratory medicines differ by diagnosis, device, technique, and control plan. This page is educational and does not replace asthma or COPD action plans, urgent care for severe symptoms, or product labeling.